Logo
Banner

HYDAMTIQ

HYDAMTIQ

Catalog No.: PC0133

Size: 50 mg, 100mg, 250mg.


Description

HYDAMTIQ is a PARP-1/2 inhibitor (IC50: 29-38 nM) with anticancer, anti-inflammatory, and ischemic protective effects. HYDAMTIQ inhibits PARP activity in the lungs, is effective against allergen-induced cough and dyspnea, and suppresses bronchial hyperresponsiveness to methacholine. HYDAMTIQ has broad-spectrum tumor suppressor effects, including ovarian and breast cancer, prostate and pancreatic cancer, and glioblastoma multiforme.

Molecular Weight 274.34
Formula C14H14N2O2S
CAS No. 1201832-32-7
SMILES O=C1NC2=C(C=C(CN(C)C)S2)C3=C(O)C=CC=C31
Shipping Room temperature in continental US; may vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
All of our services are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.